Literature DB >> 35585573

Correlation analysis of adverse outcomes for the selective reduction of twin pregnancies.

Li Gao1,2,3, Qian-Qian Xu1,2,3, Shan Wang1,2,3, Yuan-Qing Xia1,2,3, Xin-Rong Zhao1,2,3, Yi Wu1,2,3, Ren-Yi Hua1,2,3, Jin-Ling Sun1,2,3, Yan-Lin Wang4,5,6.   

Abstract

BACKGROUND: Due to the extensive development of assisted reproductive technology, the number of twin pregnancies has increased significantly over recent decades. Twin pregnancy is the most representative type of multiple pregnancies and is associated with high infant morbidity and mortality. Perinatal complications of twin pregnancy are also markedly increased compared with those of single pregnancy. Transabdominal selective reduction (SR) is a remedial intervention. This study aimed to research the adverse outcomes of transabdominal selective reduction of twin pregnancy and the correlation between the reduction week and pregnancy outcomes.
OBJECTIVE: The purpose of this study was to examine the adverse outcomes of the transabdominal selective reduction of twin pregnancy and the correlation between the reduction week and pregnancy outcomes.
METHODS: A retrospective cohort study of the transabdominal reduction of twin pregnancy was conducted in a single prenatal diagnosis medical centre from September 2012 to October 2020. According to chorionicity, women with twin pregnancies were divided into 2 groups: dichorionic (DC) twin pregnancies and monochorionic (MC) twin pregnancies. Women with DC twin pregnancies underwent potassium chloride reduction, and those with MC twin pregnancies underwent radiofrequency ablation (RFA). The reduction indications included pregnancy complications, foetal abnormalities, and maternal factors. The perinatal outcomes of different chorionic twins after reduction were analysed. Each foetus with an adverse outcome was included. The relative relationship between the reduction weeks and delivery weeks of twins was examined by correlation analysis.
RESULTS: A total of 161 women were included in this study. A total of 112 women had DC twin pregnancies, and 49 women had MC twin pregnancies. Preterm delivery rates were significantly higher in the MC twin reduction group than in the DC twin reduction group prior to 37 weeks (53.1% vs. 29.5%, P = 0.004). The mean gestational age at delivery of the foetuses in the DC twin group that underwent SR was significantly older than that of those in the MC twin group that underwent SR (36.9 ± 4.0 vs. 33.5 ± 6.6 weeks, P = 0.001). The number of DC twins that underwent SR and were delivered after 37 weeks was obviously greater than that of the MC twins that underwent SR (70.5% vs. 46.9%, P = 0.004). The foetal survival rate was 95.5% in the DC twin reduction group and 77.6% in the MC twin reduction group. If the indication of TTTS was not included, there was no significant difference in the foetal survival rate of the DC and MC twin reduction groups (95.5% vs. 86.2%, P = 0.160). Cotwin death 1 week after reduction was greater in the MC group (6.1% vs. 0%, P = 0.027). Compared to other indications, this finding indicated that a significantly lower proportion of women remained undelivered after selective reduction with the indication of TTTS. There was a significant negative correlation between the reduction weeks and delivery weeks of the two groups (P < 0.01), and the best opportunity for reduction was before 22 weeks of gestation.
CONCLUSION: These findings highlighted an obviously negative correlation between the reduction week and delivery week. The transabdominal selective reduction of twin pregnancy should be considered for a lower rate of miscarriage or premature delivery if the reduction week takes place earlier in pregnancy. The rate of preterm delivery was the lowest when transabdominal selective reduction was completed before 22 weeks of gestation. Compared with other RFA indications, a higher rate of premature delivery was shown for MC twins with a reduction indication of TTTS. TTTS with sIUGR might be one of the reasons for the adverse outcomes of reduction for MC twin pregnancy.
© 2022. The Author(s).

Entities:  

Keywords:  Adverse outcomes; Selective reduction; Transabdominal; Twin pregnancy

Mesh:

Year:  2022        PMID: 35585573      PMCID: PMC9118778          DOI: 10.1186/s12884-022-04754-4

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.105


Introduction

The rate of multiple pregnancies, especially that of twin pregnancies, has increased rapidly since assisted reproduction technologies (ARTs) have become almost explosively common worldwide in the past few decades [1, 2]. Multiple pregnancies are related to higher risks of adverse pregnancy outcomes than singleton pregnancies [3, 4]. The incidence of spontaneous abortion, prematurity, foetal dysplasia and maternal complications rise along with the foetal number [5]. Compared with singleton pregnancies, multifoetal pregnancies are associated with an approximately fivefold increased risk of stillbirth and a sevenfold increased risk of neonatal death. These adverse pregnancy outcomes are mainly due to complications of prematurity, and the risk of adverse outcomes can be lowered by reducing the number of foetuses [6, 7]. MC twin pregnancies are associated with specific complications due to placental sharing, including a higher risk of twin-twin transfusion syndrome (TTTS), foetal growth restriction, early preterm delivery and perinatal mortality. When one of the MC twins dies, with placental vascular circulation, cerebral injury or demise of the normal cotwin may occur [8]. The SR of a monochorionic (MC) twin, which is discordant for either serious structural anomalies or severe growth restriction, can, in some cases, improve the outcome for its cotwin [9, 10]. To date, few studies have analysed the correlation between reduction indications and the outcomes of MC twins. Few studies have explored the optimal choice for reducing gestational age for twins. The purpose of this study was to research the perinatal complications of transabdominal SR of twin pregnancies and the correlation between the reduction week and pregnancy outcomes.

Materials and methods

Materials

The research examined the data of all women with twin pregnancies who underwent reduction at the International Peace Maternity & Child Health Hospital (IPMCHH), Shanghai Jiaotong University, from September 20, 2012, to October 9, 2020. This study was approved by the Ethics Committee of the hospital (No. GKLW 2015–62). According to chorionicity, the twin pregnancies were divided into 2 groups: dichorionic (DC) twin pregnancies and monochorionic (MC) twin pregnancies. Women with DC twin pregnancies underwent potassium chloride reduction, and those with MC twin pregnancies underwent radiofrequency ablation (RFA). Indications for DC twin reduction included foetal factors (such as chromosomal abnormalities and foetal abnormalities) and maternal factors (such as cervical insufficiency). Indications for the use of RFA for women with MC twin pregnancies at our centre include TRAP sequence, obligate lethal discordant anomalies, severe TTTS with proximate placental cord insertion sites or sFGR type II with abnormal ultrasound blood flow indicators. The perinatal outcomes of different chorionic twins after reduction were analysed. Each foetus with an adverse outcome was included. The relative relationship between the reduction weeks and delivery weeks of the twins was examined by correlation analysis. According to chorionicity, the perinatal outcomes of the twins after SR were analysed.

Statistical analysis

All statistical analyses were performed by SPSS software (version 21; IBM Corp). Descriptive statistics included numbers and percentages for categorical variables. The data for delivery weeks are presented as the mean (±SD). Maternal age and prepregnancy BMI were assessed with the independent-samples t test. χ2 tests were used for the comparison of categorical variables and to generate the relative risks (RRs) for dichotomous outcomes and the mean differences (MDs) for continuous outcomes with 95% confidence intervals (CIs). Incidences were reported with significance accepted at a p value< 0.05. Kaplan–Meier survival analysis was performed to compare the proportion of MC twin delivery weeks for different reduction indications. Correlation analysis and ROC curve analysis was used to study the relationship between the reduction week and delivery week.

Results

Characteristics of the study population

A total of 161 women with twin pregnancies were included in this study. A total of 112 women had dichorionic (DC) twin pregnancies, and 49 women had monochorionic (MC) twin pregnancies. Women with DC twin pregnancies underwent potassium chloride reduction, and those with MC twin pregnancies underwent radiofrequency ablation (RFA). The baseline and obstetric characteristics of the study subjects are shown in Table 1. Comparisons between the two groups showed that the delivery age of foetuses in the DC twin group was significantly older than that of those in the MC twin group (P < 0.001). The spontaneous pregnancy rate was obviously lower in the DC twin group (24.1% vs. 85.7%, P < 0.001), and the rate of in vitro fertilization, as recognized, was clearly higher in the DC twin group (67.9% vs. 8.2%, P < 0.001). The proportion of parity equal to 2 was higher in the MC twin group (6.1% vs. 0%, P = 0.027).
Table 1

Baseline and obstetric characteristics of the study subjects. (According to chorionicitya)

GroupsDCMCP
Total number11249
Maternal age, n (%)
  ≥ 40 y7 (6.3)1 (2.0)0.000
 35–39 y23 (20.5)5 (10.2)
 30–34 y53 (47.3)20 (40.8)
 25–29 y28 (25.0)15 (30.6)
 20–24 y1 (0.9)7 (14.3)
  < 20 y0 (0.0)1 (2.0)
Prepregnancy BMIa, n (%)
  ≥ 30 kg/m21 (0.9)1 (2.0)0.216
 25–29 kg/m217 (15.2)8 (16.3)
 20–24 kg/m265 (58.0)32 (65.3)
  < 20 kg/m229 (25.9)8 (16.3)
Mode of conception, n (%)
 Spontaneous27 (24.1)42 (85.7)0.000
 In vitro fertilization and embryo transfer76 (67.9)4 (8.2)0.000
 Superovulation+Artificial Insemination9 (8.0)3 (6.1)0.921
Gravidity, n (%)
 147 (42.0)19 (38.8)0.705
 233 (29.5)15 (30.6)0.884
 318 (16.1)9 (18.4)0.720
 46 (5.4)5 (10.2)0.434
 56 (5.4)1 (2.0)0.596
 62 (1,8)0 (0.0)1.000
Parity, n (%)
 085 (75.9)30 (61.2)0.058
 127 (24.1)16 (32.7)0.259
 20 (0.0)3 (6.1)0.027

Chorionicity: Twins were divided into double chorionic twins and mono chorionic twins according to their chorionicity. DC Dichorionic Twins, MC Monochorionic Twins. BMI Body Mass Index, Weight (kg) divided by the square of height(m)

Baseline and obstetric characteristics of the study subjects. (According to chorionicitya) Chorionicity: Twins were divided into double chorionic twins and mono chorionic twins according to their chorionicity. DC Dichorionic Twins, MC Monochorionic Twins. BMI Body Mass Index, Weight (kg) divided by the square of height(m)

Obstetric outcomes of SR according to chorionicity

The obstetric outcomes and delivery information of women who underwent SR according to chorionicity are presented in Table 2. The preterm delivery rates were significantly higher in the MC twin reduction group than in the DC twin reduction group prior to 37 weeks (53.1% vs. 29.5%, P = 0.004). The mean gestational age at delivery of foetuses in the DC twin group that underwent SR was significantly later than that of the MC twin group that underwent SR (36.9 ± 4.0 vs. 33.5 ± 6.6 weeks, P = 0.001). The number of DC twins who underwent SR and were delivered after 37 weeks was obviously greater than that of MC twins who underwent SR (70.5% vs. 46.9%, P = 0.004). The foetal survival rate was 95.5% in the DC twin reduction group and 77.6% in the MC twin reduction group. If the indication of TTTS was not included, there was no significant difference in the foetal survival rate of the DC and MC twin reduction groups (95.5% vs. 86.2%, P = 0.160). Cotwin death 1 week after reduction was greater in the MC group (6.1% vs. 0%, P = 0.027).
Table 2

The obstetric outcomes after reduction according to chorionicity

GroupsDC N(%)MC N(%)PRisk ratio95% CI
Total number11249///
PPROMa3 (2.7)1 (2.0)1.0001.3210.134–13.026
Preterm Labour33 (29.5)26 (53.1)0.0040.3700.185–0.739
Mean GA at delivery (weeks)36.9 ± 4.033.5 ± 6.60.001/1.379–5.418
GA at birth 24–27 6/72 (1.8)4 (8.2)0.1300.2050.036–1.157
28–31 6/7 weeks6 (5.4)5 (10.2)0.4340.4980.144–1.717
32–33 6/7 weeks2 (1.8)4 (8.2)0.1300.2050.036–1.157
34–36 6/7 weeks20 (17.9)6 (12.2)0.3731.5580.584–4.158
≥37 weeks79 (70.5)23 (46.9)0.0042.7061.354–5.410
Foetal survival rate107 (95.5)38 (77.6)0.0016.1952.021–18.987
Foetal survival rate (excluding TTTS)b107 (95.5)25/29 (86.2)0.1603.4240.857–13.678
SGAc5 (4.5)5 (10.2)0.3010.4110.113–1.491
Perinatal mortality2 (1.8)4 (8.2)0.1300.2050.036–1.157
Cotwin death ≤1 week after reduction0 (0.0)1 (2.0)0.3041.0210.980–1.063
Cotwin death > 1 week after reduction0 (0.0)3 (6.1)0.0271.0650.992–1.144
GDMc16 (14.3)5 (10.2)0.4791.4670.505–4.258
HDPc8 (7.1)4 (8.2)1.0000.8650.248–3.021

a PPROM Preterm Premature Rupture Of Membranes

b Foetal survival rate (excluding TTTS): The indication of TTTS was not included for women with MC pregnancies who underwent reduction

c SGA Small for Gestational Age infant; also known as intrauterine growth retardation; a newborn whose birth weight is below the 10th percentile or 2 standard deviations below the average weight for gestational age. GDM Gestational Diabetes Mellitus. HDP Hypertensive Disorders of Pregnancy

The obstetric outcomes after reduction according to chorionicity a PPROM Preterm Premature Rupture Of Membranes b Foetal survival rate (excluding TTTS): The indication of TTTS was not included for women with MC pregnancies who underwent reduction c SGA Small for Gestational Age infant; also known as intrauterine growth retardation; a newborn whose birth weight is below the 10th percentile or 2 standard deviations below the average weight for gestational age. GDM Gestational Diabetes Mellitus. HDP Hypertensive Disorders of Pregnancy Table 3 demonstrates 17 foetuses of adverse outcomes. Eleven cases occurred for MC twins, and 6 cases occurred for DC twins. The proportion of spontaneous conception was significantly higher than that of assisted reproduction. TTTS with sIUGR was the main indication for the adverse outcomes of reduction for MC twin pregnancy. The gestational age at reduction was between 16 and 24 weeks of gestation. The main outcome of DC twin reduction was spontaneous abortion, and one case of induced labour occurred because of retained foetal malformation. The outcomes of MC twin reduction included 5 cases of cotwin death, 4 cases of spontaneous abortion, and 2 cases of induced labour for cotwin malformation.
Table 3

Cases of adverse outcomes

CaseChorionicitybG&PaMethod of conceptionReduction IndicationReduction MethodReduction WeekDelivery WeekOutcome
1MCDAbG1P0Spontaneousfoetal anomaliesRFAb1723abortion
2DCDAbG2P0Superovulationfoetal anomaliesKCLb1926abortion
3DCDAG2P0IVFfoetal anomaliesKCL1620abortion
4MCDAG2P1SpontaneousTTTS, sIUGRRFA1921stillbirth
5MCDAG3P0SpontaneousTTTSRFA2427stillbirth
6DCDAG1P0IVFfoetal anomaliesKCL2327induced labour
7DCDAG2P0IVFfoetal anomaliesKCL1920abortion
8MCDAG2P1SpontaneousTTTS, sIUGRRFA1616abortion
9MCDAG1P0Spontaneouscervical insufficiencyRFA1820abortion
10MCDAG1P0SpontaneousTTTS, sIUGRRFA2326abortion
11MCDAG1P0SpontaneousTTTS, sIUGRRFA1823induced labour
12MCDAG1P0SpontaneoussIUGRRFA1822stillbirth
13MCMAbG1P0SpontaneousTRAPsRFA1826stillbirth
14MCDAG1P0SpontaneousTTTSRFA2424stillbirth
15MCDAG2P1SpontaneousTRAPsRFA1623induced labour
16DCDAG2P0IVFfoetal anomaliesKCL1629abortion
17DCDAG5P0IVFcervical insufficiencyKCL1218abortion

a G&P: Gravidity & Parity

b Chorionicity: Twins were divided into double chorionic twins and monochorionic twins according to their chorionicity. DCDA Dichorionic Diamniotic Twins, MCDA Monochorionic Diamniotic Twins, MCMA Monochorionic Monoamniotic Twins. RFA Selective reduction using radiofrequency ablation, KCL Selective reduction using potassium chloride

Cases of adverse outcomes a G&P: Gravidity & Parity b Chorionicity: Twins were divided into double chorionic twins and monochorionic twins according to their chorionicity. DCDA Dichorionic Diamniotic Twins, MCDA Monochorionic Diamniotic Twins, MCMA Monochorionic Monoamniotic Twins. RFA Selective reduction using radiofrequency ablation, KCL Selective reduction using potassium chloride

Comparison of delivery time of MC twins with different indications after reduction

Kaplan–Meier curves showed that the proportion of women with complicated MC twin pregnancies remaining undelivered from the time of radiofrequency ablation until 41 weeks’ gestation (Fig. 1). Plots indicated that a significantly lower proportion of women remained undelivered after selective reduction with the indication of TTTS compared to that of women with other indications. An obviously higher rate of premature delivery was shown for women with a reduction indication of TTTS. The rate of premature delivery was similar for other foetal reduction indications for MC twin pregnancies.
Fig. 1

Kaplan–Meier curves according to the three types of indications

Kaplan–Meier curves according to the three types of indications

Correlation analysis between the reduction weeks and delivery weeks of twins

Sixteen foetuses with adverse outcomes before 28 weeks of delivery were excluded, and the correlation between the reduction week and delivery week of 145 foetuses was analysed (Fig. 2). The average reduction week was 19.0 ± 4.6, and the average delivery week was 37.3 ± 2.7. The Pearson correlation coefficient was −.287** (P < 0.01). There was a significant negative correlation between the reduction week and delivery week.
Fig. 2

Correlation analysis showed the relationship between the reduction weeks and delivery weeks of 145 foetuses delivered at > 28 weeks’ gestation

Correlation analysis showed the relationship between the reduction weeks and delivery weeks of 145 foetuses delivered at > 28 weeks’ gestation ROC curves were used to study the relationship between the reduction week and gestational age at delivery of all subjects (Fig. 3). The threshold for gestational age at delivery was set at later than 37 weeks. The area under the curve was 0.683 (P < 0.001), and the 95% confidence interval was 0.598–0.767. The Youden Index was 0.319, and the best opportunity for reduction was before 22 weeks of gestation.
Fig. 3

ROC Curve for reduced weeks and delivery gestational age after 37 weeks of all subjects

ROC Curve for reduced weeks and delivery gestational age after 37 weeks of all subjects

Discussion

Twin pregnancy is associated with an obviously higher risk of preterm birth and adverse pregnancy outcomes than singleton pregnancy. The reduction of a twin pregnancy to a single pregnancy might be performed to decrease the risk due to maternal history, to decrease known complications of twin pregnancy, or for social reasons. Our study showed that the preterm delivery rate was 29.5% in the DC twin reduction group and 53.1% in the MC twin reduction group. The number of DC twins who underwent SR and were delivered after 37 weeks was obviously greater than that of MC twins who underwent SR (70.5% vs. 46.9%, P = 0.004). Alvarado [11] et al. found a prematurity rate of 11.8% for preterm delivery at less than 34 weeks in the DC twin reduction group, with a miscarriage rate of 3.6%. This is analogous to our data of a 9% prematurity rate and a 4% miscarriage rate. We included 17 foetuses with adverse outcomes: 11/49 foetuses (22.4%) were MC twins, and 6/112 foetuses (5.4%) were DC twins. Adverse outcomes included abortion, stillbirth, and cotwin malformation-induced labour. The reduction week for the foetuses was between 16- and 24-weeks’ gestation. TTTS with sIUGR was the main indication for adverse outcomes of the reduction of MC twin pregnancy. The research of Kristi R revealed that sIUGR of the TTTS donor twin was an independent risk factor for donor foetal demise and thirty-day neonatal donor nonsurvival [12]. The coexistence of TTTS and SIUGR was relatively common and suggested the underlying pathophysiological relationship between these two conditions. The cause of TTTS is unequal blood flow, while the cause of sIUGR has been attributed to unequal placental sharing. Different distributions of placental blood flow might be the reason why sIUGR changed the risk of developing TTTS. These insights helped us communicate with the pregnant women and their families before intrauterine treatment. Our study suggested that RFA is an acceptable method for foetal reduction in complicated monochorionic diamniotic twins, with a foetal survival rate of nearly 80%. The pregnancy success rate following RFA selective reduction was lower for the reduction indication of TTTS (77.6%), but it was higher for other reduction indications (86.2%). There was a dramatic decline in the foetal survival rate of the MC twin reduction group (P = 0.001). If the indication of TTTS was not included, there was no significant difference in the foetal survival rate of the DC and MC twin reduction groups (P = 0.160). Our study also indicated that, compared to other indications, a significantly lower proportion of women remained undelivered after selective reduction for the indication of TTTS. A higher rate of premature delivery was shown for women with the reduction indication of TTTS. The rate of premature delivery was similar for other foetal reduction indications for MC twin pregnancies. RFA for TTTS was associated with worse outcomes than RFA for other indications [13], which might be attributable to the severity of the underlying disease and the poorer cardiovascular statuses of foetuses with TTTS. Hongmei Wang et al. performed 272 RFA procedures for 268 complicated MC pregnancies and recorded the lowest survival rate in the TTTS group (37/64, 57.8%) [14]. This result was similar to our study and previous studies [15, 16]. Kumar [17] reported that sIUGR as an indication for RFA had more favourable perinatal outcomes than other indications. We only proceeded to RFA in cases of moribund TTTS when we felt that antenatal demise of the foetus was inevitable. A case series of TRAP patients undergoing RFA at a single centre reported an overall survival rate of 92% [18]. Several studies reported that the live birth rate of twins after RFA was approximately 70–80% [19-21], which was similar to our research. All procedures were performed by a very small group of experienced foetal medicine specialists in our Foetal Medical Center, ensuring uniformity of the surgical technique and success rate. According to our research, the average reduction week was 19.0 ± 4.6, and the average delivery week was 37.3 ± 2.7. The Pearson correlation coefficient was −.287** (P < 0.01). There was a significant negative correlation between the reduction week and delivery week. ROC curves were used to study the relationship between the reduction week and gestational age at delivery of all subjects in our study. The area under the curve was 0.683 (P < 0.001), and the 95% confidence interval was 0.598–0.767. The Youden Index was 0.319, and the best opportunity for reduction was before 22 weeks of gestation. This result suggested that the ultrasonic malformation screening of twins should be performed before 21 weeks of gestation and is conducive for subsequent selective foetal reduction. Hasson reported that the rate of pregnancy complications (late abortion, preterm delivery) was significantly higher when reduction was carried out after 15 weeks of gestation (36.4% vs. 0%) [22]. Greenberg demonstrated that pregnancy was prolonged for women who underwent reduction in the first trimester (37.3 weeks) compared with the second trimester (36.4 weeks) and third trimester (35.3 weeks) [23]. One study also found that the birth weight of the foetus was significantly increased when SR was performed at a time point that was earlier than 15 weeks [24]. Bigelow et al. suggested that foetal loss and preterm delivery after SR for twin pregnancies was associated with increasing gestational age at the time of the procedure [25]. R. ZEMET’s study [26] aimed to determine the rate of perinatal complications of twin reduction in the late first trimester (11–14 weeks) compared with the second trimester (15–23 weeks) and found that the rates of preterm delivery were significantly higher in women who underwent reduction in the second trimester of pregnancy. The main strength of our study was the relatively larger sample size, and all procedures were performed by a very small group of experienced foetal medicine specialists. However, there are also several limitations in the study. This was a single-centre study with a relatively small sample size in each subgroup. The neonates in this study were not followed up for long-term neurological development. We will further strengthen our multicentre cooperation and increase the long-term follow-up of newborns. In conclusion, these findings highlighted an obviously negative correlation between the reduction week and delivery week. Foetal reduction in twin pregnancy should be considered for a lower rate of miscarriage or prematurity if the reduction week takes place earlier in pregnancy. The rate of preterm delivery was the lowest when transabdominal selective reduction was completed before 22 weeks of gestation. This suggested that the ultrasonic malformation screening of twins should be performed before 21 weeks of gestation. Compared with other RFA indications, a higher rate of premature delivery was shown for MC twins with the reduction indication of TTTS. TTTS with sIUGR might be one of the reasons for the adverse outcomes of reduction for MC twin pregnancy.
  26 in total

1.  Radiofrequency ablation vs bipolar umbilical cord coagulation in the management of complicated monochorionic pregnancies.

Authors:  M W Bebbington; E Danzer; J Moldenhauer; N Khalek; M P Johnson
Journal:  Ultrasound Obstet Gynecol       Date:  2012-09       Impact factor: 7.299

2.  Perinatal- and procedure-related outcomes following radiofrequency ablation in monochorionic pregnancy.

Authors:  Sailesh Kumar; Gowrishankar Paramasivam; Eko Zhang; Bryony Jones; Muna Noori; Tomas Prior; Akhila Vasudeva; Ruwan C Wimalasundera
Journal:  Am J Obstet Gynecol       Date:  2013-12-04       Impact factor: 8.661

3.  Selective reduction in complicated monochorionic twins: prediction of obstetric outcome and comparison of techniques.

Authors:  Y Yinon; E Ashwal; B Weisz; B Chayen; E Schiff; S Lipitz
Journal:  Ultrasound Obstet Gynecol       Date:  2015-11-04       Impact factor: 7.299

Review 4.  Practice Bulletin No. 169: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies.

Authors: 
Journal:  Obstet Gynecol       Date:  2016-10       Impact factor: 7.661

5.  Risk factors for fetal death after radiofrequency ablation for complicated monochorionic twin pregnancies.

Authors:  Luming Sun; Gang Zou; Yingjun Yang; Fenhe Zhou; Duan Tao
Journal:  Prenat Diagn       Date:  2018-05-09       Impact factor: 3.050

6.  Timing of and outcomes after selective termination of anomalous fetuses in dichorionic twin pregnancies.

Authors:  Catherine A Bigelow; Stephanie H Factor; Erin Moshier; Angela Bianco; Keith A Eddleman; Joanne L Stone
Journal:  Prenat Diagn       Date:  2014-09-30       Impact factor: 3.050

7.  Efficacy of radiofrequency ablation for twin-reversed arterial perfusion sequence.

Authors:  Hanmin Lee; Amy J Wagner; Edgar Sy; Robert Ball; Vickie A Feldstein; Ruth B Goldstein; Diana L Farmer
Journal:  Am J Obstet Gynecol       Date:  2007-05       Impact factor: 8.661

8.  Influence of indications on perinatal outcomes after radio frequency ablation in complicated monochorionic pregnancies: a retrospective cohort study.

Authors:  Hongmei Wang; Qian Zhou; Xietong Wang; Jia Song; Pengzheng Chen; Yanyun Wang; Lei Li; Hongyan Li
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-09       Impact factor: 3.007

9.  Radiofrequency ablation for selective fetal reduction in complicated Monochorionic twins; comparing the outcomes according to the indications.

Authors:  Fatemeh Rahimi-Sharbaf; Marjan Ghaemi; Ahmed A Nassr; Alireza A Shamshirsaz; Mahboobeh Shirazi
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-06       Impact factor: 3.007

10.  Comparison of perinatal outcomes in late preterm birth between singleton and twin pregnancies.

Authors:  Eun-Hye Yoo; Dasom Chun; Mi Ju Kim; Hyun-Hwa Cha; Won Joon Seong
Journal:  Obstet Gynecol Sci       Date:  2017-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.